Modified viral strains and method for improving the production of vaccine seeds of influenza virus

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8956626
APP PUB NO 20130115242A1
SERIAL NO

13809629

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Modified influenza A/PR/8/34 virus and reassortant influenza A/PR/8/34 virus including a modified PB1 gene and methods for improving the production of HA (hemagglutinin) and NA (neuraminidase) vaccine glycoproteins.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)3 RUE MICHEL ANGE PARIS 75016
HOSPICES CIVILS DE LYON3 QUAI DES CÉLESTINS LYON 69002
UNIVERSITE CLAUDE BERNARD LYON 143 BOULEVARD DU 11 NOVEMBRE 1918 VILLEURBANNE 69100

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ferraris, Olivier Bron, FR 2 11
Moules, Vincent Lyons, FR 2 3
Rosa-Calatrava, Manuel Lyons, FR 14 23
Yver, Matthieu Lyons, FR 1 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 17, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00